ScinoPharm Taiwan, Ltd. (TPE:1789)
Taiwan · Delayed Price · Currency is TWD 21.65
-0.30 (-1.37%)
At close: Feb 11, 2026
ScinoPharm Taiwan Market Cap
ScinoPharm Taiwan has a market cap or net worth of 17.12 billion as of February 20, 2026. Its market cap has decreased by -2.48% in one year.
Market Cap
17.12B
Enterprise Value
15.04B
Revenue
3.19B
Ranking
n/a
PE Ratio
90.14
Stock Price
21.65
Market Cap Chart
Since October 29, 2010, ScinoPharm Taiwan's market cap has decreased from 30.44B to 17.12B, a decrease of -43.75%. That is a compound annual growth rate of -3.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 17.12B | 29.25% |
| Dec 31, 2025 | 13.24B | -24.04% |
| Dec 31, 2024 | 17.44B | -16.48% |
| Dec 29, 2023 | 20.88B | 3.73% |
| Dec 30, 2022 | 20.12B | 3.25% |
| Dec 30, 2021 | 19.49B | -14.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Center Laboratories | 29.86B |
| TTY Biopharm Company | 20.81B |
| Grape King Bio | 18.07B |
| Alar Pharmaceuticals | 17.87B |
| Synmosa Biopharma | 16.25B |
| YungShin Global Holding | 14.73B |
| Foresee Pharmaceuticals | 13.33B |
| Handa Pharmaceuticals | 11.80B |